Huvepharma set to close tighter with €275m loan
Bulgarian animal drugs firm Huvepharma is due to close its €275m acquisition loan by the end of Wednesday, with pricing expected to tighten on the deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts